S. Lefort

发表

Cost savings of home bortezomib injection in patients with multiple myeloma treated by a combination care in Outpatient Hospital and Hospital care at Home

A. Vergnenègre, A. Jaccard, D. Bordessoule, 2016, Supportive Care in Cancer.

A case report of Down syndrome and centroblastic lymphoma.

M. Vekemans, J. Diebold, D. Satgé, 1996, Pathology, research and practice.

Cryptococcal meningitis in AIDS patients. A pilot study of fluconazole therapy in 52 patients.

A. Datry, B. Dupont, I. Hilmarsdóttir, 1990 .

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, C. Sebban, 2010, Blood.

A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia

F. Roudot-thoraval, P. Bierling, J. Viallard, 2013, Haematologica.

Molecular signals in antigen presentation. I. Effects of interleukin 1 and 2 on radiation-treated antigen-presenting cells in vivo and in vitro.

B. Benacerraf, A. Tominaga, S. Mizel, 1983, Clinical immunology and immunopathology.

Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma

R. Houot, G. Salles, P. Feugier, 2013, Haematologica.

for the Groupe d'Etude des Lymphomes de l'Adulte (GELA)

R. Houot, G. Salles, P. Feugier, 2013 .

Ruxolitinib Therapy in Myelofibrosis: Analysis of 241 Patients Treated in Compassionate Use (French “ATU” program) by the French Intergroup of Myeloproliferative Neoplasms (FIM).

P. Cony-Makhoul, B. Drénou, Anne Quinquenel, 2012 .

ANTIGEN‐PRESENTING CELLS IN IMMUNITY AND SUPPRESSION

B. Benacerraf, M. Greene, A. Tominaga, 1982 .

Therapeutic effects of interleukins on radiation-treated antigen-presenting cells in vivo and in vitro

M. Greene, A. Tominaga, S. Mizel, 1983, Survey of immunologic research.